Impact of body mass index on in-hospital complications in patients undergoing percutaneous coronary intervention in a Japanese real-world multicenter registry

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Numasawa, Yohei ^a   Kohsaka, Shun ^b   Miyata, Hiroaki ^c   Kawamura, Akio ^b   Noma, Shigetaka ^d   Suzuki, Masahiro ^e   Nakagawa, Susumu ^f   Momiyama, Yukihiko ^g   Naito, Kotaro ^h   Fukuda, Keiichi ^b  

^a ASHIKAGA RED CROSS HOSPITAL   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d Imperial Foundation Saiseikai Utsunomiya Hospital   (Japan)

^e SAITAMA NATIONAL HOSPITAL   (Japan)

^f SAISEIKAI CENTRAL HOSPITAL   (Japan)

^g NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^h Keiyu Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BODY MASS; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PERCUTANEOUS CORONARY INTERVENTION; RISK ASSESSMENT; SMOKING HABIT; ADVERSE EFFECTS; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; FACTUAL DATABASE; HEMORRHAGE; HOSPITAL; HOSPITAL MORTALITY; HYPERLIPIDEMIAS; INCIDENCE; JAPAN; MIDDLE AGED; ODDS RATIO; POSTOPERATIVE COMPLICATION; REGISTER; RISK FACTOR; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; FEMALE; HEMORRHAGE; HOSPITAL MORTALITY; HOSPITALS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; INCIDENCE; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; REGISTRIES; RISK FACTORS;

EID: 84929486041     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124399     Document Type: Article

References (47)

1. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983; 67:968-977. PMID: 6219830
2. Chen Y, Copeland WK, Vedanthan R, Grant E, Lee JE, Gu D, et al. Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort Consortium. BMJ. 2013; 347:f5446. doi: 10.1136/bmj.f5446 PMID: 24473060
3. Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet. 2014; 383:970-983. doi: 10.1016/S0140-6736(13)61836-X PMID: 24269108
4. Sarno G, Garg S, Onuma Y, Buszman P, Linke A, Ischinger T, et al. The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with Biolimus- and Sirolimus-eluting stents (from the LEADERS Trial). Am J Cardiol. 2010; 105:475-479. doi: 10.1016/j.amjcard.2009.09.055 PMID: 20152241
5. Sarno G, Raber L, Onuma Y, Garg S, Brugaletta S, van Domburg RT, et al. Impact of body mass index on the five-year outcome of patients having percutaneous coronary interventions with drug-eluting stents. Am J Cardiol. 2011; 108:195-201. doi: 10.1016/j.amjcard.2011.03.023 PMID: 21529741
6. Wang ZJ, Zhou YJ, Liu YY, Yu M, Shi DM, Zhao YX, et al. Obesity and cardiovascular thrombotic events in patients undergoing percutaneous coronary intervention with drug-eluting stents. Heart. 2009; 95:1587-1592. doi: 10.1136/hrt.2009.172395 PMID: 19592387
7. Angeras O, Albertsson P, Karason K, Ramunddal T, Matejka G, James S, et al. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. Eur Heart J. 2013; 34:345-353. doi: 10.1093/eurheartj/ehs217 PMID: 22947610
8. Lancefield T, Clark DJ, Andrianopoulos N, Brennan AL, Reid CM, Johns J, et al. Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry. JACC Cardiovasc Interv. 2010; 3:660-668. doi: 10.1016/j.jcin.2010.03.018 PMID: 20630460
9. Delhaye C, Wakabayashi K, Maluenda G, Belle L, Ben-Dor I, Gonzalez MA, et al. Body mass index and bleeding complications after percutaneous coronary intervention: does bivalirudin make a difference?Am Heart J. 2010; 159:1139-1146. doi: 10.1016/j.ahj.2010.03.011 PMID: 20569731
10. Benderly M, Boyko V, Goldbourt U. Relation of body mass index to mortality among men with coronary heart disease. Am J Cardiol. 2010; 106:297-304. doi: 10.1016/j.amjcard.2010.03.078 PMID: 20643236
11. Oreopoulos A, Padwal R, Norris CM, Mullen JC, Pretorius V, Kalantar-Zadeh K. Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis. Obesity (Silver Spring). 2008; 16:442-450. doi: 10.1038/oby.2007.36 PMID: 18239657
12. Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?J Am Coll Cardiol. 2002; 39:578-584. PMID: 11849854
13. Mak KH, Bhatt DL, Shao M, Haffner SM, Hamm CW, Hankey GJ, et al. The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease. Eur Heart J. 2009; 30:857-865. doi: 10.1093/eurheartj/ehp037 PMID: 19233855
14. Byrne J, Spence MS, Fretz E, Mildenberger R, Chase A, Berry B, et al. Body mass index, periprocedural bleeding, and outcome following percutaneous coronary intervention (from the British Columbia Cardiac Registry). Am J Cardiol. 2009; 103:507-511. doi: 10.1016/j.amjcard.2008.10.027 PMID: 19195511
15. Ndrepepa G, Fusaro M, Cassese S, Guerra E, Schunkert H, Kastrati A. Relation of Body Mass Index to Bleeding During Percutaneous Coronary Interventions. Am J Cardiol. 2014; 115:434-440. doi: 10.1016/j.amjcard.2014.11.022 PMID: 25547940
16. Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J. 2008; 156:13-22. doi: 10.1016/j.ahj.2008.02.014 PMID: 18585492
17. Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J. 2007; 153:74-81. PMID: 17394906
18. Mobeirek AF, Al-Habib K, Al-Faleh H, Hersi A, Kashour T, Ullah A, et al. Absence of obesity paradox in Saudi patients admitted with acute coronary syndromes: insights from SPACE registry. Annals of Saudi medicine. 2014; 34:38-45. doi: 10.5144/0256-4947.2014.38 PMID: 24658552
19. Herrmann J, Gersh BJ, Goldfinger JZ, Witzenbichler B, Guagliumi G, Dudek D, et al. Body mass index and acute and long-term outcomes after acute myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial). Am J Cardiol. 2014; 114:9-16. doi: 10.1016/j.amjcard.2014.03.057 PMID: 24846807
20. Witassek F, Schwenkglenks M, Erne P, Radovanovic D. Impact of Body Mass Index on mortality in Swiss hospital patients with ST-elevation myocardial infarction: does an obesity paradox exist? Swiss medical weekly. 2014; 144:w13986. doi: 10.4414/smw.2014.13986 PMID: 25102276
21. Wang TY, Chen AY, Roe MT, Alexander KP, Newby LK, Smith SC Jr, et al. Comparison of baseline characteristics, treatment patterns, and in-hospital outcomes of Asian versus non-Asian white Americans with non-ST-segment elevation acute coronary syndromes from the CRUSADE quality improvement initiative. Am J Cardiol. 2007; 100:391-396. PMID: 17659915
22. Kohsaka S, Kimura T, Goto M, Lee VV, Elayda M, Furukawa Y, et al. Difference in patient profiles and outcomes in Japanese versus American patients undergoing coronary revascularization (collaborative study by CREDO-Kyoto and the Texas Heart Institute Research Database). Am J Cardiol. 2010; 105:1698-1704. doi: 10.1016/j.amjcard.2010.01.349 PMID: 20538117
23. Sasayama S. Heart disease in Asia. Circulation. 2008; 118(25):2669-2671. doi: 10.1161/CIRCULATIONAHA.108.837054 PMID: 19106388
24. Numasawa Y, Kohsaka S, Miyata H, Kawamura A, Noma S, Suzuki M, et al. Safety of transradial approach for percutaneous coronary intervention in relation to body mass index: a report from a Japanese multicenter registry. Cardiovasc Interv Ther. 2013; 28:148-156. doi: 10.1007/s12928-012-0138-8 PMID: 23054968
25. Numasawa Y, Kohsaka S, Miyata H, Kawamura A, Noma S, Suzuki M, et al. Use of Thrombolysis in Myocardial Infarction Risk Score to predict bleeding complications in patients with unstable angina and non-ST elevation myocardial infarction undergoing percutaneous coronary intervention. Cardiovasc Interv Ther. 2013; 28:242-249. doi: 10.1007/s12928-013-0162-3 PMID: 23361950
26. Ohno Y, Maekawa Y, Miyata H, Inoue S, Ishikawa S, Sueyoshi K, et al. Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention. J Am Coll Cardiol. 2013; 62:1260-1266. doi: 10.1016/j.jacc.2013.03.086 PMID: 23770181
27. Kuno T, Numasawa Y, Miyata H, Takahashi T, Sueyoshi K, Ohki T, et al. Impact of coronary dominance on in-hospital outcomes after percutaneous coronary intervention in patients with acute coronary syndrome. PLoS One. 2013; 8:e72672. doi: 10.1371/journal.pone.0072672 PMID: 23991136
28. Numasawa Y, Kohsaka S, Miyata H, Noma S, Suzuki M, Ishikawa S, et al. Gender differences in in-hospital clinical outcomes after percutaneous coronary interventions: an insight from a Japanese multicenter registry. PLoS One. 2015; 10:e0116496. doi: 10.1371/journal.pone.0116496 PMID: 25635905
29. Mehta SK, Frutkin AD, Lindsey JB, House JA, Spertus JA, Rao SV, et al. Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circ Cardiovasc Interv. 2009; 2:222-229. doi: 10.1161/CIRCINTERVENTIONS.108.846741 PMID: 20031719
30. Kaneko H, Yajima J, Oikawa Y, Tanaka S, Fukamachi D, Suzuki S, et al. Obesity paradox in Japanese patients after percutaneous coronary intervention: An observation cohort study. J Cardiol. 2013; 62:18-24. doi: 10.1016/j.jjcc.2013.02.009 PMID: 23706354
31. Kosuge M, Kimura K, Kojima S, Sakamoto T, Ishihara M, Asada Y, et al. Impact of body mass index on in-hospital outcomes after percutaneous coronary intervention for ST segment elevation acute myocardial infarction. Circ J. 2008; 72:521-525. PMID: 18362419
32. Steinberg BA, Cannon CP, Hernandez AF, Pan W, Peterson ED, Fonarow GC. Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database. Am J Cardiol. 2007; 100:1331-1335. PMID: 17950785
33. Payvar S, Kim S, Rao SV, Krone R, Neely M, Paladugu N, et al. In-Hospital Outcomes of Percutaneous Coronary Interventions in Extremely Obese and Normal-Weight Patients: Findings From the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol. 2013; 62:692-696. doi: 10.1016/j.jacc.2013.05.058 PMID: 23948513
34. Das SR, Alexander KP, Chen AY, Powell-Wiley TM, Diercks DB, Peterson ED, et al. Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-Segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol. 2011; 58:2642-2650. doi: 10.1016/j.jacc.2011.09.030 PMID: 22152950
35. Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006; 368:666-678. PMID: 16920472
36. Cox N, Resnic FS, Popma JJ, Simon DI, Eisenhauer AC, Rogers C. Comparison of the risk of vascular complications associated with femoral and radial access coronary catheterization procedures in obese versus nonobese patients. Am J Cardiol. 2004; 94:1174-1177. PMID: 15518615
37. Niraj A, Pradhan J, Fakhry H, Veeranna V, Afonso L. Severity of coronary artery disease in obese patients undergoing coronary angiography: "obesity paradox" revisited. Clin Cardiol. 2007; 30:391-396. PMID: 17680619
38. Diercks DB, Roe MT, Mulgund J, Pollack CV Jr, Kirk JD, Gibler WB, et al. The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative. Am Heart J. 2006; 152:140-148. PMID: 16824844
39. Ahmed B, Piper WD, Malenka D, VerLee P, Robb J, Ryan T, et al. Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry. Circ Cardiovasc Interv. 2009; 2:423-429. doi: 10.1161/CIRCINTERVENTIONS.109.860494 PMID: 20031752
40. Gurm HS, Brennan DM, Booth J, Tcheng JE, Lincoff AM, Topol EJ. Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox). Am J Cardiol. 2002; 90:42-45. PMID: 12088778
41. Ndrepepa G, Berger PB, Mehilli J, Seyfarth M, Neumann FJ, Schomig A, et al. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol. 2008; 51:690-697. doi: 10.1016/j.jacc.2007.10.040 PMID: 18279731
42. Daugherty SL, Thompson LE, Kim S, Rao SV, Subherwal S, Tsai TT, et al. Patterns of use and comparative effectiveness of bleeding avoidance strategies in men and women following percutaneous coronary interventions: an observational study from the national cardiovascular data registry. J Am Coll Cardiol. 2013; 61:2070-2078. doi: 10.1016/j.jacc.2013.02.030 PMID: 23524046
43. Brueck M, Bandorski D, Kramer W, Wieczorek M, Holtgen R, Tillmanns H. A randomized comparison of transradial versus transfemoral approach for coronary angiography and angioplasty. JACC Cardiovasc Interv. 2009; 2:1047-1054. doi: 10.1016/j.jcin.2009.07.016 PMID: 19926042
44. Gurm HS, Whitlow PL, Kip KE. The impact of body mass index on short- and long-term outcomes inpatients undergoing coronary revascularization. Insights from the bypass angioplasty revascularization investigation (BARI). J Am Coll Cardiol. 2002; 39:834-840. PMID: 11869849
45. Kang SJ, Mintz GS, Witzenbichler B, Metzger DC, Rinaldi MJ, Duffy PL, et al. Effect of obesity on coronary atherosclerosis and outcomes of percutaneous coronary intervention: grayscale and virtual histology intravascular ultrasound substudy of assessment of dual antiplatelet therapy with drug-eluting stents. Circ Cardiovasc Interv. 2015; 8(1). doi: 10.1161/CIRCINTERVENTIONS.114.002079 PMID: 25593122
46. Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE Jr, Ettinger SM, et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2011; 57:e215-367. doi: 10.1016/j.jacc.2011.02.011 PMID: 21545940
47. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007; 28:1598-1660. PMID: 17569677